*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*                                                                     *x*
*x*            Copyright (C) 1990 University of Pennsylvania            *x*
*x*                                                                     *x*
*x*    The data in this file are part of a preliminary version of the   *x*
*x*    Penn Treebank Corpus.  Any research using this corpus or based   *x*
*x*    on it should acknowledge that fact, as well as the preliminary   *x*
*x*    nature of the corpus.                                            *x*
*x*                                                                     *x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*
*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*x*



======================================

[ Scientists/NNS ]
at/IN 
[ the/DT University/NNP ]
of/IN 
[ Washington/NNP ]
and/CC at/IN 
[ the/DT Oncogen/NNP division/NN ]
of/IN 
[ Bristol-Myers/NNP Co./NNP ]
said/VBD 
[ they/PRP ]
developed/VBD 
[ a/DT live/JJ ]
genetically/RB engineered/VBN 
[ vaccine/NN ]

[ that/WDT ]
protected/VBD 
[ macaque/JJ monkeys/NNS ]
against/IN 
[ infection/NN ]
by/IN 
[ simian/JJ AIDS/NNP virus/NN ]
./. 

======================================

[ Four/CD animals/NNS ]
immunized/VBN with/IN 
[ the/DT vaccine/NN ]
were/VBD exposed/VBN to/TO 
[ the/DT simian/JJ AIDS/NNP virus/NN ]
,/, and/CC 
[ all/DT four/CD ]
have/VBP remained/VBN 
[ healthy/JJ ]
and/CC 
[ virus-free/JJ ]
throughout/IN 
[ a/DT 32-week/JJ follow-up/NN period/NN ]
./. 

[ Three/CD ]
of/IN 
[ the/DT study/NN 's/POS four/CD non-vaccinated/JJ control/NN animals/NNS ]
became/VBD infected/VBN within/IN 
[ two/CD weeks/NNS ]
./. 

[ A/DT fourth/JJ control/NN animal/NN ]
remained/VBD 
[ uninfected/JJ ]
./. 

======================================

While/IN 
[ other/JJ scientists/NNS ]
,/, notably/RB 
[ polio/NN pioneer/NN Jonas/NNP Salk/NNP ]
and/CC 
[ Ronald/NNP DesRosiers/NNP ]
of/IN 
[ Harvard/NNP University/NNP ]
,/, have/VBP recently/RB reported/VBN 
[ strides/NNS ]
in/IN 
[ animal/NN vaccine/NN development/NN ]
,/, 
[ Oncogen/NNP ] 
said/VBD 
[ its/PRP$ work/NN ]
represents/VBZ 
[ another/DT kind/NN ]
of/IN 
[ first/NN ]
./. 

======================================

``/`` 
[ We/PRP ]
believe/VBP that/IN 
[ this/DT ]
is/VBZ 
[ the/DT ]
first/JJ 
[ live/JJ ]
,/, 
[ recombinant/JJ vaccine/NN ]

[ that/WDT ]
protects/VBZ 
[ primates/NNS ]
against/IN 
[ a/DT retrovirus/NN ]

[ that/WDT ]
causes/VBZ 
[ AIDS-like/JJ diseases/NNS ]
,/, ''/'' said/VBD 
[ Shiu-Lok/NNP Hu/NNP ]
,/, 
[ who/WP ]
is/VBZ 
[ director/NN ]
of/IN 
[ vaccine/NN research/NN ]
at/IN 
[ Oncogen/NNP ]
and/CC 
[ the/DT senior/JJ author/NN ]
of/IN 
[ a/DT report/NN ]
on/IN 
[ the/DT work/NN ]
published/VBN in/IN 
[ the/DT current/JJ issue/NN ]
of/IN 
[ the/DT Proceedings/NNP ]
of/IN 
[ the/DT National/NNP Academy/NNP ]
of/IN 
[ Sciences/NNP ]
./. 

[ He/PRP ]
cautioned/VBD that/IN 
[ the/DT findings/NNS ]
are/VBP n't/RB directly/RB transferrable/JJ to/TO 
[ human/JJ AIDS/NNP ]
,/, but/CC said/VBD 
[ the/DT methodology/NN ]
offers/VBZ 
[ promise/NN ]
for/IN 
[ further/JJ research/NN ]
./. 

======================================

[ The/DT study/NN animals/NNS ]
were/VBD innoculated/VBN with/IN 
[ two/CD doses/NNS ]
of/IN 
[ vaccine/NN ]
spaced/VBN 
[ 16/CD weeks/NNS ]
apart/RB ,/, and/CC then/RB exposed/VBN to/TO live/JJ 
[ simian/JJ AIDS/NNP virus/NN 12/CD weeks/NNS ]
after/IN 
[ the/DT second/JJ innoculation/NN ]
./. 

======================================

[ The/DT vaccine/NN ]
,/, called/VBD 
[ v-senv5/NNP splices/VBZ ]
together/RB 
[ part/NN ]
of/IN 
[ the/DT virus/NN 's/POS protein/NN coat/NN ]
to/TO 
[ the/DT vaccinia/NN ]
or/CC 
[ cowpox/NN virus/NN ]
,/, long/RB used/VBN in/IN 
[ smallpox/NN immunization/NN ]
./. 

======================================

[ Scientists/NNS ]
said/VBD 
[ the/DT advantage/NN ]
of/IN 
[ a/DT live/JJ ]
,/, 
[ recombinant/JJ virus/NN vaccine/NN ]
is/VBZ that/IN 
[ it/PRP ]
continues/VBZ to/TO offer/VB 
[ protection/NN ]
even/RB when/WRB 
[ exposure/NN ]
to/TO 
[ the/DT virus/NN ]
occurs/VBZ long/RB after/IN 
[ immunization/NN ]
./. 
